Advertisement
Screener

United Therapeutics Corporation (UTHR) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

United Therapeutics Corporation Cash Flow Breakdown

Cash flow breakdown shows where United Therapeutics Corporation's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $1.56B came in.
  • Fiscal year ended 2025-12-31: from investing, $551.30M went out.
  • Fiscal year ended 2025-12-31: from financing, $1.15B went out.
  • Fiscal year ended 2025-12-31: change in cash, $140.10M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksCommercial paperStaff share taxNew shares soldOtherNot split outChange in cash
2025-12-31$1.56B-$551.30M-$1.00B-$300.00M*-$16.60M$173.90M-$7.30M*-$140.10M
2024-12-31$1.33B$417.20M-$1.00B-$400.00M*-$12.20M$152.50M$4.90M*$489.50M
2023-12-31$978.00M-$719.60M$0.00-$100.00M*-$13.80M$98.00M$3.90M*$246.50M
2022-12-31$802.50M-$811.50M$0.00$0.00*-$11.40M$88.40M-$1.60M*$66.40M
2021-12-31$598.20M-$486.90M$0.00*-$10.80M$50.00M$5.60M*$156.10M
2020-12-31$755.70M-$738.50M-$50.00M*-$3.70M$33.80M$3.00M*$300.00K
2019-12-31-$206.60M-$335.40M$600.00M*-$2.10M$9.90M$3.40M*$69.20M
2018-12-31$778.40M-$820.60M$0.00*$0.00$15.60M-$9.30M*-$35.90M
2017-12-31$474.20M-$835.60M-$250.00M$250.00M$39.90M$3.40M*-$317.90M
2016-12-31$643.60M$48.30M-$500.00M$7.70M$5.90M-$11.30M*$191.20M
2015-12-31$382.80M$503.60M-$394.50M$39.30M$37.40M-$129.20M*$434.10M
2014-12-31$355.30M$338.50M-$483.10M$140.00M$50.20M$30.80M-$314.50M*$113.40M
2013-12-31$425.27M-$294.97M-$42.44M$26.61M$9.30M$1.41M*$124.86M
2012-12-31$323.63M-$163.36M-$188.00M$16.80M$3.05M-$999.00K*-$8.65M
2011-12-31$250.19M-$121.33M-$212.00M$24.40M$11.35M-$41.82M*-$89.49M
2010-12-31$211.53M-$209.24M$85.43M$23.83M$37.50M*$151.81M
2009-12-31$99.72M-$162.62M$32.07M$4.41M-$29.10M
2008-12-31-$40.43M-$181.24M$41.94M$21.09M$150.00M*-$9.87M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksCommercial paperStaff share taxNew shares soldOtherNot split outChange in cash
2026-06-30$313.60M*$87.50M*$0.00*$0.00*-$500.00K*$126.30M*-$3.40M*
2026-03-31$463.30M$743.70M-$1.50B$0.00-$58.30M$68.30M$5.60M*-$277.40M
2025-12-31$346.20M*-$227.60M*$0.00*$0.00*-$600.00K*$99.00M*
2025-09-30$562.10M*$140.90M*-$1.00B*$0.00*-$500.00K*$40.20M*$4.30M*
2025-06-30$191.70M*-$299.90M*$0.00*-$400.00M*-$200.00K*$18.10M*$183.50M*
2025-03-31$461.20M-$164.70M$0.00-$100.00M-$15.30M$16.60M$4.90M*$202.70M
2024-12-31$341.20M*-$123.20M*$0.00*-$100.00M*-$300.00K*$25.70M*
2024-09-30$377.20M*-$114.90M*$0.00*-$100.00M*-$400.00K*$32.50M*$3.80M*
2024-06-30$232.20M*-$80.00M*$0.00*-$100.00M*-$100.00K*$52.10M*
2024-03-31$376.50M$735.30M-$1.00B-$100.00M-$11.40M$42.20M$1.20M*$43.80M
2023-12-31$150.70M*$42.10M*$0.00*-$100.00M*-$100.00K*$7.30M*
2023-09-30$346.20M*-$313.40M*$0.00*$0.00*-$200.00K*$4.60M*$3.20M*
2023-06-30$106.30M*-$227.20M*$0.00*$0.00*$0.00*$24.70M*
2023-03-31$374.80M-$221.10M$0.00$0.00*-$13.50M$61.40M$700.00K*$202.30M
2022-12-31$128.20M*-$189.30M*$0.00*$0.00*$55.50M*
2022-09-30$258.60M*-$94.00M*$0.00*-$300.00K*$4.70M*$2.60M*
2022-06-30$127.00M*-$169.00M*$0.00*$0.00*$23.90M*
2022-03-31$288.70M-$359.20M$0.00*-$11.10M$4.30M*-$81.50M
2021-12-31$174.60M*-$195.80M*$0.00*-$200.00K*$7.70M*
2021-09-30$185.60M*-$235.90M*$0.00*-$200.00K*$14.00M*$2.80M*
2021-06-30$148.20M*-$48.90M*$0.00*-$200.00K*$10.80M*
2021-03-31$89.80M-$6.30M$0.00*-$10.20M$17.50M$2.80M*$93.60M
2020-12-31$126.20M*-$63.80M*$0.00*-$100.00K*$7.90M*-$1.70M*
2020-09-30$250.90M*-$271.70M*$0.00*-$100.00K*$3.50M*$2.20M*
2020-06-30$164.00M*-$375.40M*$0.00*-$100.00K*$21.70M*
2020-03-31$214.60M-$27.60M-$50.00M-$3.40M$700.00K$2.50M*$136.80M
2019-12-31$102.50M*$66.20M*-$150.00M*$0.00*$0.00*
2019-09-30$185.40M*-$298.70M*-$50.00M*-$200.00K*$0.00*$1.90M*
2019-06-30$132.90M*-$42.60M*$0.00*$0.00*$1.10M*
2019-03-31-$627.40M-$60.30M$800.00M-$1.90M*$8.80M$121.40M
2018-12-31$85.40M*-$72.20M*$0.00*$100.00K*$13.20M*
2018-09-30$237.50M*-$329.90M*$0.00*$600.00K*$1.80M*-$89.90M*
2018-06-30$179.80M*-$359.80M*$5.70M*-$12.50M*-$186.80M*
2018-03-31$275.70M-$58.70M$9.20M$1.40M*$227.60M
2017-12-31-$85.80M*-$278.40M*$0.00*$0.00*$1.70M*-$362.40M*
2017-09-30$258.50M*-$200.20M*$0.00*$0.00*$1.60M*$1.90M*$61.60M*
2017-06-30$70.70M*-$191.40M*$3.60M*-$116.70M*
2017-03-31$230.80M-$165.60M$33.00M$1.40M*$99.60M
2016-12-31$163.40M*$8.50M*-$104.50M*$1.50M*$1.30M*$70.00M*
2016-09-30$228.70M*$20.10M*-$135.80M*$1.20M*$1.10M*$1.20M*$115.50M*
2016-06-30$125.70M*$7.70M*-$136.50M*$2.40M*$1.40M*-$7.80M*-$9.30M*
2016-03-31$125.80M$12.00M-$123.20M$2.60M$2.10M-$4.70M*$15.00M
2015-12-31$25.50M*$56.50M*$0.00*$6.30M*$6.00M*-$26.10M*$66.60M*
2015-09-30$207.20M*$347.60M*-$57.70M*$8.60M*$7.90M*-$700.00K*$510.80M*
2015-06-30$41.00M*$31.10M*-$184.50M*$14.30M*$14.80M*-$90.30M*-$172.10M*
2015-03-31$109.10M$68.40M-$152.30M$10.10M$8.70M-$12.10M*$28.80M
2014-12-31$90.65M*$51.99M*-$79.94M*$0.00*$10.81M*$7.62M*-$177.83M*-$99.63M*
2014-09-30$208.54M*$97.95M*-$25.60M*-$75.00M*$17.22M*$9.14M*$1.66M*$232.88M*
2014-06-30-$54.48M*$82.18M*-$279.93M*$13.79M*$8.43M*$74.94M*-$154.75M*
2014-03-31$110.60M$106.38M-$97.63M$8.38M$5.61M$1.73M*$134.91M
2013-12-31$104.42M*-$156.35M*-$1.00K*$6.71M*$3.49M*-$1.32M*-$43.34M*
2013-09-30$139.30M*-$175.82M*$0.00*$9.80M*$3.17M*$1.42M*-$21.32M*
2013-06-30$83.85M*$26.57M*-$36.53M*$5.84M*$1.67M*$81.42M*
2013-03-31$97.70M$10.63M-$5.90M$4.26M$962.00K$1.38M*$108.10M
2012-12-31$105.21M*-$164.70M*-$57.08M*$7.12M*$970.00K*-$109.39M*
2012-09-30$93.45M*$47.61M*-$42.92M*$6.58M*$1.40M*$106.41M*
2012-06-30$87.39M*-$287.00K*$1.30M*$366.00K*-$88.00M*$347.00K*
2012-03-31$37.59M-$45.99M$1.81M$318.00K-$6.01M
2011-12-31$51.63M*$16.18M*$450.00K*$4.86M*-$253.82M*-$181.31M*
2011-09-30$80.68M*-$57.96M*$224.00K*$197.00K*$22.86M*
2011-06-30$64.54M*-$44.21M*$9.75M*$2.31M*$32.16M*
2011-03-31$53.35M-$35.34M$13.98M$3.98M$36.80M
2010-12-31$39.25M*-$63.31M*$21.00M*$5.10M*$37.50M*$41.98M*
2010-09-30$102.83M*-$191.08M*$9.82M*$2.37M*-$75.22M*
2010-06-30$35.23M*$36.93M*$18.27M*$5.60M*$95.45M*
2010-03-31$34.22M$8.23M$36.33M$10.76M$89.60M
2009-12-31$26.32M*-$68.03M*$9.04M*$1.70M*-$34.15M*
2009-09-30$15.99M*-$33.60M*$16.92M*$1.12M*$978.00K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Viatris Inc (VTRS)United States$20.008B-0.00
Royalty Pharma plc (RPRX)United States$22.628B
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
INSMED Inc (INSM)United States$26.566B-26.60
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17